ACTRN12611000648921RecruitingNot Applicable
In patients with psoriasis vulgaris, can supplementation with vitamin D3 improve psoriasis as measured by Psoriasis Area and Severity Index score?
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Massey University
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomised controlled trial
- Primary Purpose
- Treatment
Eligibility Criteria
- Ages
- 18 Years to o limit (—)
- Sex
- All
Inclusion Criteria
- •Medically diagnosed psoriasis vulgaris
Exclusion Criteria
- •Smoking; chronic kidney or liver disease; currently taking vitamin D supplements, or have taken them within the past two months; pregnant or lactating, or planning to be in the near future; have commenced a new psoriasis treatment within the past three months and wish to continue
Investigators
Similar Trials
Completed
Not Applicable
A Pilot Study of Topical Honey for the Treatment of PsoriasisPsoriasisSkin - Dermatological conditionsACTRN12612000562875Medical Research Institute of New Zealand15
Active, not recruiting
Not Applicable
/AEUCTR2006-002523-16-SESynphora AB
Completed
Not Applicable
Management of moderate to severe plaque psoriasis with Kyntheum® in daily practicePsoriasis vulgarisL40.0DRKS00013604EO Pharma GmbH668
Withdrawn
Phase 4
Optimizing the treatment of psoriasis with methotrexate; after 40 years the first dose-finding study.psoriasis10014982NL-OMON37246Academisch Medisch Centrum80
Completed
Not Applicable
The effectiveness of psoriasis guidelinesPsoriasisSkin and Connective Tissue DiseasesISRCTN92654180HS R&D Regional Programme Register - Department of Health (UK)